Last reviewed · How we verify
Hepatitis E serology
At a glance
| Generic name | Hepatitis E serology |
|---|---|
| Sponsor | Hospices Civils de Lyon |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases (NA)
- Long-term Effectiveness of a Recombinant Hepatitis E Vaccine
- Utility of EUS-elastography to Predict Portal Hypertension
- Hepatitis E Virus Infection in Pediatric Transplantation, a Prevalence Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hepatitis E serology CI brief — competitive landscape report
- Hepatitis E serology updates RSS · CI watch RSS
- Hospices Civils de Lyon portfolio CI